Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03538288 · ClinicalTrials.gov registry record · NA

Feasibility Trial of rTMS for Cannabis Use Disorder

A NA study of Cannabis, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT03538288: Completed NA study of Cannabis, sponsored by Medical University of South Carolina.

NCT03538288 is a NA study of Cannabis that has completed, run by Medical University of South Carolina. The registered enrollment target is 3 participants, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03538288, a NA study of Cannabis, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment paradigm. The investigators are primarily seeking to determine if the proposed paradigm is feasible and well tolerated.

Primary Outcome

The investigators will test the hypothesis that at least 50% of enrolled participants will complete the trial.

Conditions Studied

Interventions

  • DEVICE rTMS

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2016-10-01
Est. Completion 2017-07-01
Phase NA

What the finished NCT03538288 record still lists

NCT03538288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.

NCT03538288 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03538288 about?

NCT03538288 is a clinical study titled "Feasibility Trial of rTMS for Cannabis Use Disorder". This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment paradigm. The investigators are primarily seeking to determine if the proposed paradigm is feasible and well tol...

What is the current status of trial NCT03538288?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2016-10-01. Estimated completion is 2017-07-01.

What conditions does trial NCT03538288 study?

This clinical trial studies the following conditions: Cannabis.

What interventions are being tested in trial NCT03538288?

The interventions under investigation include: rTMS (DEVICE).

Who is sponsoring clinical trial NCT03538288?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03538288 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03538288's enrollment target sits among peer trials

3 25th of 24 the lowest of 24 other Cannabis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cannabis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03538288, the US trial registry maintained by the National Library of Medicine. NCT03538288 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.